Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.
Read More…
Industry, Sector and Symbol
Industry Skilled nursing care facilities
Sub-IndustryN/A
SectorMedical
Phone610-444-6350
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$4.98 billion
Profitability
Miscellaneous
Employees61,300
Next Earnings Date11/6/2019 (Estimated)
OptionableOptionable
Genesis Healthcare (NYSE:GEN) Frequently Asked Questions
What is Genesis Healthcare's stock symbol?
Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."
How were Genesis Healthcare's earnings last quarter?
Genesis Healthcare Inc (NYSE:GEN) posted its earnings results on Thursday, August, 8th. The company reported ($0.05) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.13) by $0.08. The business had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.15 billion. During the same quarter in the prior year, the firm posted ($0.39) earnings per share. View Genesis Healthcare's Earnings History.
When is Genesis Healthcare's next earnings date?
What price target have analysts set for GEN?
3 Wall Street analysts have issued 1 year price targets for Genesis Healthcare's stock. Their forecasts range from $1.75 to $7.00. On average, they anticipate Genesis Healthcare's stock price to reach $3.75 in the next twelve months. This suggests a possible upside of 171.7% from the stock's current price. View Analyst Price Targets for Genesis Healthcare.
What is the consensus analysts' recommendation for Genesis Healthcare?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genesis Healthcare in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Genesis Healthcare.
Has Genesis Healthcare been receiving favorable news coverage?
Media stories about GEN stock have been trending positive this week, InfoTrie reports. The research firm ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Genesis Healthcare earned a news impact score of 2.1 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Genesis Healthcare.
Who are some of Genesis Healthcare's key competitors?
Some companies that are related to Genesis Healthcare include Odonate Therapeutics (ODT), Y-mAbs Therapeutics (YMAB), Luminex (LMNX), Corindus Vascular Robotics (CVRS), Mesoblast (MSB), Cryolife (CRY), Spectrum Pharmaceuticals (SPPI), ANI Pharmaceuticals (ANIP), Stratec (SBS), Phibro Animal Health (PAHC), Shockwave Medical (SWAV), Opthea (OPT), Tactile Systems Technology (TCMD), Athenex (ATNX) and Endo International (ENDP).
What other stocks do shareholders of Genesis Healthcare own?
Who are Genesis Healthcare's key executives?
Genesis Healthcare's management team includes the folowing people:
- Mr. George V. Hager Jr., CEO & Director (Age 63)
- Mr. Thomas DiVittorio, CFO, Exec. VP, Treasurer & Assistant Sec. (Age 51)
- Mr. Paul David Bach, COO & Exec. VP (Age 60)
- Dr. JoAnne Susan Reifsnyder Ph.D., MSN, MBA, FAAN, Exec. VP of Clinical Operations & Chief Nursing Officer (Age 60)
- Mr. Richard L. Castor, Chief Information Officer & Sr. VP (Age 64)
How do I buy shares of Genesis Healthcare?
Shares of GEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Genesis Healthcare's stock price today?
One share of GEN stock can currently be purchased for approximately $1.38.
How big of a company is Genesis Healthcare?
Genesis Healthcare has a market capitalization of $227.40 million and generates $4.98 billion in revenue each year. The company earns $-235,230,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis. Genesis Healthcare employs 61,300 workers across the globe.View Additional Information About Genesis Healthcare.
What is Genesis Healthcare's official website?
How can I contact Genesis Healthcare?
Genesis Healthcare's mailing address is 101 EAST STATE STREET, KENNETT SQUARE PA, 19348. The company can be reached via phone at 610-444-6350 or via email at [email protected]
MarketBeat Community Rating for Genesis Healthcare (NYSE GEN)
MarketBeat's community ratings are surveys of what our community members think about Genesis Healthcare and other stocks. Vote "Outperform" if you believe GEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
